Antitumor Activity of HM781-36B, alone or in Combination with Chemotherapeutic Agents, in Colorectal Cancer Cells. [electronic resource]
Producer: 20180611Description: 355-64 p. digitalISSN:- 2005-9256
- Antineoplastic Agents -- administration & dosage
- Apoptosis -- drug effects
- Camptothecin -- analogs & derivatives
- Cell Line, Tumor
- Cell Survival -- drug effects
- Colorectal Neoplasms -- drug therapy
- Drug Synergism
- ErbB Receptors -- antagonists & inhibitors
- Extracellular Signal-Regulated MAP Kinases -- metabolism
- Fluorouracil -- pharmacology
- G1 Phase Cell Cycle Checkpoints -- drug effects
- Humans
- Irinotecan
- Organoplatinum Compounds -- pharmacology
- Oxaliplatin
- Protein Biosynthesis -- drug effects
- Protein-Tyrosine Kinases -- antagonists & inhibitors
- Proto-Oncogene Proteins c-akt -- metabolism
- Quinazolines -- administration & dosage
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.